PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-Mar-2022 NextRNA Launches with $56 Million in Funding to Bring Transformative Non-Coding RNA-Directed Medicines to Patients Businesswire
01-Mar-2022 Epizyme Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update Businesswire
01-Mar-2022 Meghan Rivera Appointed US Managing Director, Organon Businesswire
01-Mar-2022 Global Drug-Device Combinations Markets Report 2022: Data from 2020, Estimates from 2021, & CAGR Projections Through 2026 - ResearchAndMarkets.com Businesswire
01-Mar-2022 Carmot announces Tim Garnett M.D., previously Chief Medical Officer Eli Lilly, joins Carmot’s Board of Directors Businesswire
01-Mar-2022 North Bay Startup LARASAH Launches Results-Focused Solution for Burnout Businesswire
01-Mar-2022 United Therapeutics Corporation to Present at the Cowen 42nd Annual Health Care Conference Businesswire
01-Mar-2022 Biodesix to Present at Cowen’s 42nd Annual Healthcare Conference Businesswire
01-Mar-2022 Model N Management to Present at the JMP Securities Technology Conference Businesswire
01-Mar-2022 The Worldwide Acerola Extract Industry is Expected to Reach $24 Million by 2026 - ResearchAndMarkets.com Businesswire
01-Mar-2022 BeiGene to Present at the Cowen 42nd Annual Health Care Virtual Conference Businesswire
01-Mar-2022 HKSTP Takes Talent Mission to New Level with T2 – Hong Kong’s First-Ever Innovation Tech x Talent Month Businesswire
01-Mar-2022 CARVYKTI™ (ciltacabtagene autoleucel), BCMA-Directed CAR-T Therapy, Receives U.S. FDA Approval for the Treatment of Adult Patients With Relapsed or Refractory Multiple Myeloma Businesswire
01-Mar-2022 FDA nimmt BLA-Antrag von Alvotech an, der die Austauschbarkeit von ATV02 unterstützt, einem hochkonzentrierten, zitratfreien Biosimilar-Kandidaten für Humira® Businesswire
01-Mar-2022 La FDA accepte la demande d'autorisation de mise sur le marché de produit biologique (Biologics License Application, BLA) d'Alvotech pour la substituabilité de l'Humira® par ATV02, un candidat biosimilaire haute concentration sans citrate Businesswire
01-Mar-2022 extractX Ltd. Announces Financial Results for the First Quarter of 2022 Businesswire
28-Feb-2022 Kinetik Wellbeing and St John Ambulance expand partnership into New Zealand Kinetik Wellbeing
28-Feb-2022 ERGOMED announces launch of its Rare Disease Innovation Center™ ERGOMED
28-Feb-2022 Kinetik Wellbeing working with NHS’s Monitor My Health to provide at-home blood test kits Kinetik Wellbeing
28-Feb-2022 Ferrer Announces Distribution Agreement With United Therapeutics for Treprostinil Inhalation Solution for Pulmonary Hypertension Associated With Interstitial Lung Disease Newswire